Study on Clinical Effectiveness of L-Oxiracetam Injection

NCT04205565 PHASE3 UNKNOWN

A randomized, double-blind, positive drug/placebo parallel controlled, multicenter, phase III clinical trial of L-oxiracetam injection to improve memory and cognitive Impairment in patients with craniocerebral injury.

Details

Lead sponsor	Nanjing Yoko Biomedical Co., Ltd.
Phase	PHASE3
Status	UNKNOWN
Enrolment	591
Start date	Mon Sep 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Oct 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Craniocerebral Injury

Interventions

• Test group: L-oxiracetam Injection
• Control group: Oxiracetam Injection
• Placebo group: Placebo Injection

Countries

China